Article Information
History
- June 12, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Tingjie Wang1,2,*,
- Lingxi Tian3,*,
- Bing Wei1,2,
- Jun Li1,2,
- Cuiyun Zhang1,2,
- Ruitao Long5,
- Xiaofei Zhu4,6,
- Yougai Zhang1,2,
- Bo Wang1,2,
- Jun Yang3,# and
- Yongjun Guo1,2,#
- 1Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
- 2Henan Key Laboratory of Molecular Pathology, Zhengzhou, China
- 3MOE Key Laboratory of Intelligent Biomanufacturing, School of Bioengineering, Dalian University of Technology, Dalian 116024, PR China
- 4Department of clinical laboratory, the third affiliated hospital of Xinxiang Medical University,
- 5School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 6Henan Key Laboratory of Immunology and Targeted Drugs, Xinxiang Key Laboratory of Tumor Microenvironment and Immunotherapy, School of Medical Technology, Xinxiang Medical University
- ↵#Corresponding authors: yongjunguo{at}hotmail.com; junyang{at}dlut.edu.cn. Address: The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital Zhengzhou, Henan, P. R. China.
↵* These authors contributed equally to this work.